Delcath Systems Inc (DCTH.OQ)

DCTH.OQ on NASDAQ Stock Exchange Capital Market

2.29USD
22 Aug 2014
Price Change (% chg)

$0.17 (+8.02%)
Prev Close
$2.12
Open
$2.10
Day's High
$2.37
Day's Low
$2.10
Volume
55,637
Avg. Vol
15,805
52-wk High
$10.56
52-wk Low
$1.90

DCTH.OQ

Chart for DCTH.OQ

About

Delcath Systems, Inc. (Delcath) is a development-stage, specialty pharmaceutical and medical device company, focused on oncology, initially cancers in the liver. Delcath focuses on the development and clinical study of the Delcath chemosaturation system. The Delcath chemosaturation system allows the administration of concentrate... (more)
No analyst recommendations are available for DCTH.OQ.

Overall

Beta: 2.50
Market Cap (Mil.): $21.64
Shares Outstanding (Mil.): 9.45
Dividend: --
Yield (%): --

Financials

  DCTH.OQ Industry Sector
P/E (TTM): -- 32.13 34.50
EPS (TTM): -2.84 -- --
ROI: -- 10.11 17.96
ROE: -- 11.99 18.65
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: S&P Capital IQ Quantitative Report
$115.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks